Takeda Pharmaceutical Company Limited
OTC: TKPHF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Christophe Weber
- Employees
- 49,281
- Headquarters
- Tokyo, Japan
- IPO year
- 2008
- Market cap
- $51.3B
- Website
- https://www.takeda.com
Loading TKPHF…
Loading profile data…Frequently asked questions about TKPHF
What does Takeda Pharmaceutical Company Limited (TKPHF) do?
Takeda Pharmaceutical Company Limited, an established global biopharmaceutical entity founded in 1781 and based in Tokyo, Japan, is comprehensively involved in the entire process of bringing new medicines to market. This includes the research, development, production, commercialization, and external licensing of its pharmaceutical products acros...
Where does TKPHF trade?
Takeda Pharmaceutical Company Limited (TKPHF) trades on the Other OTC.
What sector is TKPHF in?
Takeda Pharmaceutical Company Limited (TKPHF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Takeda Pharmaceutical Company Limited?
Christophe Weber is the chief executive officer of Takeda Pharmaceutical Company Limited (TKPHF).
Where is Takeda Pharmaceutical Company Limited headquartered?
Takeda Pharmaceutical Company Limited is headquartered in Japan.
Does TKPHF pay a dividend?
Yes — Takeda Pharmaceutical Company Limited (TKPHF) paid a trailing twelve-month dividend of USD 1.30 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did TKPHF go public?
Takeda Pharmaceutical Company Limited (TKPHF) completed its initial public offering in 2008.